Association between future events of brain infarction and soluble levels of intercellular adhesion molecule-1 and C-reactive protein in patients with type 2 diabetes mellitus

Diabetes Research and Clinical Practice

Volumn 82, Issue 2, 2008, Pages 157-164

  Kanai, Akio ^a   Kawamura, Takahiko ^a   Umemura, Tositaka ^a   Nagashima, Masahito ^a   Nakamura, Nobuhisa ^a   Nakayama, Mikihiro ^a   Sano, Takahisa ^a   Nakashima, Eitaro ^b   Hamada, Yoji ^b   Nakamura, Jiro ^b   Hotta, Nigishi ^a  

^a CHUBU ROSAI HOSPITAL   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Brain infarction; C reactive protein; Diabetes mellitus; Intercellular adhesion molecule 1

Indexed keywords

C REACTIVE PROTEIN; CREATININE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INTERCELLULAR ADHESION MOLECULE 1; TRIACYLGLYCEROL; URIC ACID;

ADULT; AGED; ARTICLE; BRAIN INFARCTION; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETIC MICROANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DISEASE DURATION; FEMALE; FOLLOW UP; GLYCEMIA CONTROL INDEX; HIGH RISK PATIENT; HUMAN; HYPERTENSION; MACROALBUMINURIA; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK FACTOR; SYMPTOMATOLOGY; SYSTOLIC BLOOD PRESSURE;

AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; BLOOD PRESSURE; BRAIN INFARCTION; C-REACTIVE PROTEIN; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MALE; MIDDLE AGED; TRIGLYCERIDES; URIC ACID;

EID: 54549092446     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2008.07.006     Document Type: Article

References (39)

1. Abbott R.D., and Donahue R.P. Diabetes and the risk of stroke: the Honolulu Heart Program. J. Am. Med. Assoc. 257 (1987) 949-952
2. Mankovsky B.N., and Ziegler D. Stroke in patients with diabetes mellitus. Diabetes Metab. Res. Rev. 20 (2004) 268-287
3. Tanizaki Y., Kiyohara Y., Kato I., Iwamoto H., Nakayama K., Shinohara N., et al. Incidence and risk factors for subtype of cerebral infarction in general population: the Hisayama study. Stroke 31 (2000) 2616-2622
4. Iso H., Kitamura A., Sato S., Naito Y., Tanigawa T., Ohira T., et al. Type 2 diabetes and risk of non-embolic ischaemic stroke in Japanese men and women. Diabetologia 47 (2004) 2137-2144
5. Langhone P., Stott D.J., Roberson L., MacDonald J., Jones L., McAipine C., et al. Medical complication after stroke: a multicenter study. Stroke 31 (2000) 1223-1229
6. Aruz A., Murillo L., Cantu C., Barinagarrementeria F., and Higuera J. Prospective study of single and multiple lacunar infarcts using magnetic resonance imaging: risk factors, recurrence, and outcome in 175 consecutive cases. Stroke 34 (2003) 2453-2458
7. Ross R. The pathogenesis of atherosclerosis-an update. N. Engl. J. Med. 314 (1986) 488-500
8. Ridker P.M., Hennekens C.H., Buring J.E., and Rifai N. C-reactive protein and others of inflammation in the prediction of cardiovascular disease in women. N. Engl. J. Med. 342 (2000) 836-843
9. Curb J.D., Abbott R.D., Rodriguez B.L., Sakkinen P., Popper J.S., Yano K., et al. C-reactive protein and future risk of thromboembolic stroke in healthy men. Circulation 107 (2003) 2016-2020
10. Wakugawa Y., Kiyohara Y., Tanizaki Y., Kubo M., Ninomiya T., Hata J., et al. C-reactive protein and risk of first-ever ischemic and hemorrhagic stroke in general Japanese population: the Hisayama study. Stroke 37 (2006) 27-32
11. Price D.T., and Loscalzo J. Cellular adhesion molecules and atherogenesis. Am. J. Med. 107 (1999) 85-97
12. Hwang S.-J., Ballantyne M., Sharrett R., Smith L.C., Davis C.E., Gotto Jr. A.M., et al. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the atherosclerosis risk in communities (ARIC) study. Circulation 96 (1997) 4219-4225
13. Blankenberg S., Barbaux S., and Tiret L. Adhesion molecules and atherosclerosis. Atherosclerosis 170 (2003) 191-203
14. Ridker P.M., Hennekens C.H., Roitman-Johnson B., Stampfer M.J., and Allen J. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy. Lancet 351 (1998) 88-92
15. Blankenberg S., Rupprecht H.J., Bickel C., Peetz D., Hafner G., Tiret L., et al. Circulating cell adhesion molecules and death in patients with coronary artery disease. Circulation 104 (2001) 1336-1342
16. Tanne D., Haim M., Boyko V., Goldbourt U., Reshef T., Matetzky S., et al. Soluble intercellular adhesion molecule-1 and risk of future ischemic stroke: a nested case-control study from the bezafibrate infarction prevention (BIP) study cohort. Stroke 33 (2002) 2182-2186
17. Kawamura T., Umemura T., Kanai A., Uno T., Matsumae H., Sano T., et al. The incidence and characteristics of silent cerebral infarction in elderly diabetic patients: association with serum-soluble adhesion molecules. Diabetologia 41 (1998) 911-917
18. Kawamura T., Umemura T., Kanai A., Nagashima M., Nakamura N., Uno T., et al. Soluble adhesion molecules and C-reactive protein in the progression of silent cerebral infarction in patients with type 2 diabetes mellitus. Metabolism 55 (2006) 461-466
19. Ledue T.B., Weiner D.L., Sipe J.D., Poulin S.E., Collins M.F., and Rifai N. Analytical evaluation of particle-enhanced immunonephelometric assays for C-reactive protein, serum amyloid A and mannose-binding protein in human serum. Ann. Clin. Biochem. 35 (1998) 745-753
20. Kannel W.B., Wolf P.A., McGee D.L., Dawber T.R., McNamara P., and Castelli W.P. Systolic blood pressure, arterial rigidity, and risk of stroke: the Framingham study. J. Am. Med. Assoc. 245 (1981) 1225-1229
21. Tanizaki Y., Kiyohara Y., Kato Y., Iwamoto H., Nakayama K., Shinohara N., et al. Incidence and risk factors for subtypes of cerebral infarction in a general population: the Hisayama study. Stroke 31 (2000) 2616-2622
22. Hu G., Sarti C., Jousilahti P., Peltonen M., Qiao Q., Antikainen R., et al. The impact of history of hypertension and type 2 diabetes at baseline on the incidence of stroke and stroke mortality. Stroke 36 (2005) 2538-2543
23. Kuusisto J., Mykkänen L., Pyörälä K., and Laakso M. Non-insulin-dependent diabetes and its metabolic control are important predictors of stroke in elderly subjects. Stroke 25 (1994) 1157-1164
24. Selvin E., Coresh J., Shahar E., Zhang L., Steffes M., and Sharrett A.R. Glycaemia (haemoglobinA1c) and incident ischaemic stroke: the Atherosclerosis Risk in Communities (ARIC) study. Lancet Neurol. 4 (2005) 821-826
25. Vermeer S.E., Sandee W., Algra A., Koudstaal P., Kappelle L.J., Dippel D.W.J., et al. Impaired glucose tolerance increase stroke risk in nondiabetic patients with transient ischemic attack or minor ischemic stroke. Stroke 37 (2006) 1413-1417
26. Folsom A.R., Rasmussen M.L., Howard G., Cooper L., Scumidt M.I., and Heiss G. Prospective associations of fasting insulin, body fat distribution, and diabetes with risk of ischemic stroke. Diabetes Care 22 (1999) 1077-1083
27. Giorda C.B., Avogaro A.A., Maggini M., Lombardo F., Mannucci E., Turco S., et al. Incidence and risk factors for stroke in type 2 diabetic patients: the DAI study. Stroke 38 (2007) 1154-1160
28. Vermeer S.E., dem Heijer T., Koudstaal P.J., Oudkerk M., Hofman A., and Breteler M.B. Incidence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study. Stroke 34 (2003) 392-396
29. Ishikawa J., Tamura Y., Hoshide S., Eguchi K., Ishikawa S., Kazuyuki S., et al. Low-grade inflammation is a risk factor for clinical stroke events in addition to silent cerebral infarcts in Japanese older hypertensives: the Jichi Medical School ABPM study, Wave 1. Stroke 38 (2007) 911-917
30. Eguchi K., Kario K., and Shimada K. Greater impact of coexistence of hypertension and diabetes on silent cerebral infarcts. Stroke 34 (2003) 2471-2474
31. Ehrensperger E., Minuk J., Durcan L., Mackey A., Wolfson C., Fontaine A.-M., et al. Predictive value of soluble intercellular adhesion molecule-1 for risk of ischemic events in individuals with cerebrovascular disease. Cerebrovasc. Dis. 20 (2005) 456-462
32. Miller M., Zhan M., and Havas S. High attributable risk of elevated C-reactive protein levels to conventional coronary heart disease risk factors: the third National Health and Nutrition Examination Survey. Arch. Int. Med. 165 (2005) 2063-2068
33. Luc G., Arveiler D., Evans A., Amouyel P., Ferrieres J., Bard J.-M., et al. Circulating adhesion molecules ICAM-1 and VCAM-1 and incident coronary heart disease: the PRIME study. Atherosclerosis 170 (2003) 169-176
34. Ceriello A., Quagliaro L., Piconi L., Assaloni R., Da Ros R., Maier A., et al. Effect of postprandial hypertriglycceridemia and hyperglycemia on circulating adhesion molecules and oxidative stress generation and the possible role of simvastatin treatment. Diabetes 53 (2004) 701-710
35. Schram M.T., Chaturvedi N., Schalkwijk C., Giorgino F., Ebelling P., Fuller J.H., et al. Vascular risk factors and markers of endothelial function as determinants of inflammatory markers in Type 1 diabetes. Diabetes Care 26 (2003) 2165-2173
36. Cholesterol Treatment Trialists' (CTT) Collaborators. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90056 participants in 14 randomised trials of statins. Lancet 366 (2005) 1267-1278
37. Ray K.K., Morrow D.A., Shui A., Rifai N., and Cannon C.P. Relation between soluble intercellular adhesion molecule-1, statin therapy, and long-term risk of clinical cardiovascular events in patients with previous acute coronary syndrome (from PROVE IT-TIMI 22). Am. J. Cardiol. 98 (2006) 861-865
38. Wilcox R., Bousser M.-G., Betteridge J., Schernthaner G., Pirags V., Kupfer S., et al. Effects of pioglitazone in patients with type 2 diabetes with or without previous stroke: results from PROactive (Prospective pioglitazone clinical trial in macrovascular events 04). Stroke 38 (2007) 865-873
39. Mochizuki S., Dahlöf B., Shimizu M., Ikewaki K., Yoshikawa M., Taniguchi I., et al. Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study): a randomised, open-label, blinded endpoint morbidity-mortality study. Lancet 369 (2007) 1431-1439